The DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
Aptamer chemistry
Abstract
ABSTRACT Aptamers are single‐stranded DNA or RNA molecules capable of tightly binding to specific targets. These functional nucleic acids are obtained by an in vitro Darwinian evolution method coined SELEX (Systematic Evolution of Ligands by EXponential enrichment). Compared to their proteinaceous counterparts, aptamers offer a number of advantages including a low immunogenicity, a relative ease of large‐scale synthesis at affordable costs with little or no batch‐to‐batch variation, physical stability, and facile chemical modification. These alluring properties have propelled aptamers into the forefront of numerous practical applications such as the development of therapeutic and diagnostic agents as well as the construction of biosensing platforms. However, commercial success of aptamers still proceeds at a weak pace. The main factors responsible for this delay are the susceptibility of aptamers to degradation by nucleases, their rapid renal filtration, suboptimal thermal stability, and the lack of functional group diversity. Here, we describe the different chemical methods available to mitigate these shortcomings. Particularly, we describe the chemical post‐SELEX processing of aptamers to include functional groups as well as the inclusion of modified nucleoside triphosphates into the SELEX protocol. These methods will be illustrated with successful examples of chemically modified aptamers used as drug delivery systems, in therapeutic applications, and as biosensing devices. Graphical abstract Figure. No Caption available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning
Alipanahi, B., Delong, A., Weirauch, M. T., & Frey, B. J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3300 · Cited by 2,873
Keefe, A. D., Pai, S., & Ellington, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3141 · Cited by 2,289
Aptamers as targeted therapeutics: current potential and challenges
Zhou, J., & Rossi, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.199 · Cited by 2,221
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Aptamers evolved from live cells as effective molecular probes for cancer study
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., & Tan, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602615103 · Cited by 1,516
Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA
Robertson, D. L., & Joyce, G. F. (1990) · Nature · doi:10.1038/344467a0 · Cited by 1,331
The chemical evolution of oligonucleotide therapies of clinical utility
Khvorova, A., & Watts, J. K. (2017) · Nature Biotechnology · doi:10.1038/nbt.3765 · Cited by 1,216
Target identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
Bagalkot, V., Zhang, L., Levy-Nissenbaum, E., Jon, S., Kantoff, P. W., Langer, R., & Farokhzad, O. C. (2007) · Nano Letters · doi:10.1021/nl071546n · Cited by 1,036
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Analysis of aptamer discovery and technology
Dunn, M. R., Jimenez, R. M., & Chaput, J. C. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0076 · Cited by 938
Development of DNA aptamers using Cell-SELEX
Sefah, K., Shangguan, D., Xiong, X., O'Donoghue, M. B., & Tan, W. (2010) · Nature Protocols · doi:10.1038/nprot.2010.66 · Cited by 918
Functional Aptamers and Aptazymes in Biotechnology, Diagnostics, and Therapy
Famulok, M., Hartig, J. S., & Mayer, G. (2007) · Chemical Reviews · doi:10.1021/cr0306743 · Cited by 887
Effective drug delivery by PEGylated drug conjugates
Greenwald, R. B., Choe, Y. H., McGuire, J., & Conover, C. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00180-1 · Cited by 869
The delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 854
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
Geary, R. S., Norris, D., Yu, R., & Bennett, C. F. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.008 · Cited by 845
Connecting genetic risk to disease end points through the human blood plasma proteome
Suhre, K., Arnold, M., Bhagwat, A. M., Cotton, R. J., Engelke, R., Raffler, J., Sarwath, H., Thareja, G., Wahl, A., DeLisle, R. K., et al. (2017) · Nature Communications · doi:10.1038/ncomms14357 · Cited by 800
LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition
Singh, S. K., Koshkin, A. A., Wengel, J., & Nielsen, P. (1998) · Chemical Communications · doi:10.1039/a708608c · Cited by 768
Current prospects for RNA interference-based therapies
Davidson, B. L., & McCray, P. B. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2968 · Cited by 761
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
Expanding and reprogramming the genetic code
Chin, J. W. (2017) · Nature · doi:10.1038/nature24031 · Cited by 737
Synthetic genetic polymers capable of heredity and evolution
Pinheiro, V. B., Taylor, A. I., Cozens, C., Abramov, M., Renders, M., Zhang, S., Chaput, J. C., Wengel, J., Peak-Chew, S.-Y., McLaughlin, S. H., et al. (2012) · Science · doi:10.1126/science.1217622 · Cited by 730
Reymond, J.-L. (2015) · Accounts of Chemical Research · doi:10.1021/ar500432k · Cited by 720
Current approaches in SELEX: An update to aptamer selection technology
Darmostuk, M., Rimpelova, S., Gbelcova, H., & Ruml, T. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.02.008 · Cited by 702
Obika, S., Nanbu, D., Hari, Y., Andoh, J.-I., Morio, K.-I., Doi, T., & Imanishi, T. (1998) · Tetrahedron Letters · doi:10.1016/s0040-4039(98)01084-3 · Cited by 700
Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
Eckstein, F. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2014.0506 · Cited by 684
A semi-synthetic organism with an expanded genetic alphabet
Malyshev, D. A., Dhami, K., Lavergne, T., Chen, T., Dai, N., Foster, J. M., Corrêa, I. R., & Romesberg, F. E. (2014) · Nature · doi:10.1038/nature13314 · Cited by 616
FDA-Approved Oligonucleotide Therapies in 2017
Stein, C. A., & Castanotto, D. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.023 · Cited by 608
Nimjee, S. M., White, R. R., Becker, R. C., & Sullenger, B. A. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104558 · Cited by 607
Dassie, J. P., Liu, X.-Y., Thomas, G. S., Whitaker, R. M., Thiel, K. W., Stockdale, K. R., Meyerholz, D. K., McCaffrey, A. P., McNamara, J. O., & Giangrande, P. H. (2009) · Nature Biotechnology · doi:10.1038/nbt.1560 · Cited by 589
Rohloff, J. C., Gelinas, A. D., Jarvis, T. C., Ochsner, U. A., Schneider, D. J., Gold, L., & Janjic, N. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.49 · Cited by 533
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
Wahlestedt, C., Salmi, P., Good, L., Kela, J., Johnsson, T., Hökfelt, T., Broberger, C., Porreca, F., Lai, J., Ren, K., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5633 · Cited by 520
RNA aptamers as reversible antagonists of coagulation factor IXa
Rusconi, C. P., Scardino, E., Layzer, J., Pitoc, G. A., Ortel, T. L., Monroe, D., & Sullenger, B. A. (2002) · Nature · doi:10.1038/nature00963 · Cited by 512
Generation of high-affinity DNA aptamers using an expanded genetic alphabet
Kimoto, M., Yamashige, R., Matsunaga, K.-I., Yokoyama, S., & Hirao, I. (2013) · Nature Biotechnology · doi:10.1038/nbt.2556 · Cited by 510
Pi, F., Binzel, D. W., Lee, T. J., Li, Z., Sun, M., Rychahou, P., Li, H., Haque, F., Wang, S., Croce, C. M., et al. (2018) · Nature Nanotechnology · doi:10.1038/s41565-017-0012-z · Cited by 494
Mirror-image RNA that binds D-adenosine
Klußmann, S., Nolte, A., Bald, R., Erdmann, V. A., & Fürste, J. P. (1996) · Nature Biotechnology · doi:10.1038/nbt0996-1112 · Cited by 399
Assessment of Variability in the SOMAscan Assay
Candia, J., Cheung, F., Kotliarov, Y., Fantoni, G., Sellers, B., Griesman, T., Huang, J., Stuccio, S., Zingone, A., Ryan, B. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14755-5 · Cited by 393
Small-Molecule Binding Aptamers: Selection Strategies, Characterization, and Applications
Ruscito, A., & DeRosa, M. C. (2016) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00014 · Cited by 391
Phosphorothioate Oligodeoxynucleotides: What Is Their Origin and What Is Unique About Them?
ECKSTEIN, F. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.117 · Cited by 382
Reversible Cell‐Specific Drug Delivery with Aptamer‐Functionalized Liposomes
Cao, Z., Tong, R., Mishra, A., Xu, W., Wong, G. C. L., Cheng, J., & Lu, Y. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901452 · Cited by 372
Modified deoxyoligonucleotides stable to exonuclease degradation in serum
Shaw, J.-P., Kent, K., Bird, J., Fishback, J., & Froehler, B. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.4.747 · Cited by 369
Catalytic DNA: Scope, Applications, and Biochemistry of Deoxyribozymes
Silverman, S. K. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.04.010 · Cited by 364
A semi-synthetic organism that stores and retrieves increased genetic information
Zhang, Y., Ptacin, J. L., Fischer, E. C., Aerni, H. R., Caffaro, C. E., San Jose, K., Feldman, A. W., Turner, C. R., & Romesberg, F. E. (2017) · Nature · doi:10.1038/nature24659 · Cited by 354
Direct In Vitro Selection of a 2′-O-Methyl Aptamer to VEGF
Burmeister, P. E., Lewis, S. D., Silva, R. F., Preiss, J. R., Horwitz, L. R., Pendergrast, P. S., McCauley, T. G., Kurz, J. C., Epstein, D. M., Wilson, C., et al. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.10.017 · Cited by 347
Antidote-mediated control of an anticoagulant aptamer in vivo
Rusconi, C. P., Roberts, J. D., Pitoc, G. A., Nimjee, S. M., White, R. R., Quick, G., Scardino, E., Fay, W. P., & Sullenger, B. A. (2004) · Nature Biotechnology · doi:10.1038/nbt1023 · Cited by 339
In vitro selection with artificial expanded genetic information systems
Sefah, K., Yang, Z., Bradley, K. M., Hoshika, S., Jiménez, E., Zhang, L., Zhu, G., Shanker, S., Yu, F., Turek, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311778111 · Cited by 330
Aptamer Selection Technology and Recent Advances
Blind, M., & Blank, M. (2015) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.74 · Cited by 322
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
Ni, S., Yao, H., Wang, L., Lu, J., Jiang, F., Lu, A., & Zhang, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081683 · Cited by 321
Expanding the Chemistry of DNA for in Vitro Selection
Vaught, J. D., Bock, C., Carter, J., Fitzwater, T., Otis, M., Schneider, D., Rolando, J., Waugh, S., Wilcox, S. K., & Eaton, B. E. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908035g · Cited by 313
Wang, A. Z., Bagalkot, V., Vasilliou, C. C., Gu, F., Alexis, F., Zhang, L., Shaikh, M., Yuet, K., Cima, M. J., Langer, R., et al. (2008) · ChemMedChem · doi:10.1002/cmdc.200800091 · Cited by 312
Forty Years of In Vitro Evolution
Joyce, G. F. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200701369 · Cited by 307
Shamah, S. M., Healy, J. M., & Cload, S. T. (2008) · Accounts of Chemical Research · doi:10.1021/ar700142z · Cited by 304
Amplification, Mutation, and Sequencing of a Six-Letter Synthetic Genetic System
Yang, Z., Chen, F., Alvarado, J. B., & Benner, S. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja204910n · Cited by 302
Pharmacokinetics and Biodistribution of Novel Aptamer Compositions
Healy, J. M., Lewis, S. D., Kurz, M., Boomer, R. M., Thompson, K. M., Wilson, C., & McCauley, T. G. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7676-4 · Cited by 298
Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates
Lee, J. H., Yigit, M. V., Mazumdar, D., & Lu, Y. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.003 · Cited by 293
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy
Hathout, Y., Brody, E., Clemens, P. R., Cripe, L., DeLisle, R. K., Furlong, P., Gordish-Dressman, H., Hache, L., Henricson, E., Hoffman, E. P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507719112 · Cited by 290
Discovery and Biosensing Applications of Diverse RNA-Cleaving DNAzymes
Liu, M., Chang, D., & Li, Y. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.7b00262 · Cited by 290
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function
Schmidt, K. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh862 · Cited by 287
Gilbert, J. C., DeFeo-Fraulini, T., Hutabarat, R. M., Horvath, C. J., Merlino, P. G., Marsh, H. N., Healy, J. M., BouFakhreddine, S., Holohan, T. V., & Schaub, R. G. (2007) · Circulation · doi:10.1161/circulationaha.107.724864 · Cited by 286
Antisense oligonucleotides in therapy for neurodegenerative disorders
Evers, M. M., Toonen, L. J. A., & van Roon-Mom, W. M. C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.008 · Cited by 286
Griffin, L., Tidmarsh, G., Bock, L., Toole, J., & Leung, L. (1993) · Blood · doi:10.1182/blood.v81.12.3271.3271 · Cited by 285
Generation of Species Cross-reactive Aptamers Using “Toggle” SELEX
White, R., Rusconi, C., Scardino, E., Wolberg, A., Lawson, J., Hoffman, M., & Sullenger, B. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0495 · Cited by 284
Catalysts from synthetic genetic polymers
Taylor, A. I., Pinheiro, V. B., Smola, M. J., Morgunov, A. S., Peak-Chew, S., Cozens, C., Weeks, K. M., Herdewijn, P., & Holliger, P. (2015) · Nature · doi:10.1038/nature13982 · Cited by 272
In vivo selection of tumor-targeting RNA motifs
Mi, J., Liu, Y., Rabbani, Z. N., Yang, Z., Urban, J. H., Sullenger, B. A., & Clary, B. M. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.277 · Cited by 269
Darwinian evolution of an alternative genetic system provides support for TNA as an RNA progenitor
Yu, H., Zhang, S., & Chaput, J. C. (2012) · Nature Chemistry · doi:10.1038/nchem.1241 · Cited by 268
Recognition of Anionic Porphyrins by DNA Aptamers
Li, Y., Geyer, R., & Sen, D. (1996) · Biochemistry · doi:10.1021/bi960038h · Cited by 268
Sacca, B. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki257 · Cited by 259
Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation
Lao, Y.-H., Phua, K. K. L., & Leong, K. W. (2015) · ACS Nano · doi:10.1021/nn507494p · Cited by 259
Therapeutic RNA aptamers in clinical trials
Sundaram, P., Kurniawan, H., Byrne, M. E., & Wower, J. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.10.014 · Cited by 259
Davies, D. R., Gelinas, A. D., Zhang, C., Rohloff, J. C., Carter, J. D., O’Connell, D., Waugh, S. M., Wolk, S. K., Mayfield, W. S., Burgin, A. B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213933109 · Cited by 256
Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer® therapeutics
Vater, A., & Klussmann, S. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.004 · Cited by 250
Optimization and Modifications of Aptamers Selected from Live Cancer Cell Lines
Shangguan, D., Tang, Z., Mallikaratchy, P., Xiao, Z., & Tan, W. (2007) · ChemBioChem · doi:10.1002/cbic.200600532 · Cited by 250
Yu, R. Z., Kim, T.-W., Hong, A., Watanabe, T. A., Gaus, H. J., & Geary, R. S. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012401 · Cited by 244
Lee, J.-H., Canny, M. D., De Erkenez, A., Krilleke, D., Ng, Y.-S., Shima, D. T., Pardi, A., & Jucker, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509069102 · Cited by 242
Evolution of Functional Six-Nucleotide DNA
Zhang, L., Yang, Z., Sefah, K., Bradley, K. M., Hoshika, S., Kim, M.-J., Kim, H.-J., Zhu, G., Jiménez, E., Cansiz, S., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b02251 · Cited by 238
Campbell, J. M., Bacon, T. A., & Wickstrom, E. (1990) · Journal of Biochemical and Biophysical Methods · doi:10.1016/0165-022x(90)90084-p · Cited by 230
Aptamer-conjugated nanomaterials and their applications
Yang, L., Zhang, X., Ye, M., Jiang, J., Yang, R., Fu, T., Chen, Y., Wang, K., Liu, C., & Tan, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.002 · Cited by 226
Selection and Biosensor Application of Aptamers for Small Molecules
Pfeiffer, F., & Mayer, G. (2016) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00025 · Cited by 224
Dyke, C. K., Steinhubl, S. R., Kleiman, N. S., Cannon, R. O., Aberle, L. G., Lin, M., Myles, S. K., Melloni, C., Harrington, R. A., Alexander, J. H., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.668434 · Cited by 222
Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor
Pagratis, N. C., Bell, C., Chang, Y.-F., Jennings, S., Fitzwater, T., Jellinek, D., & Dang, C. (1997) · Nature Biotechnology · doi:10.1038/nbt0197-68 · Cited by 221
Potent 2'-Amino-2'-deoxypyrimidine RNA Inhibitors of Basic Fibroblast Growth Factor
Jellinek, D., Green, L. S., Bell, C., Lynott, C. K., Gill, N., Vargeese, C., Kirschenheuter, G., McGee, D. P. C., & Abesinghe, P. (1995) · Biochemistry · doi:10.1021/bi00036a009 · Cited by 215
In vivo SELEX for Identification of Brain-penetrating Aptamers
Cheng, C., Chen, Y. H., Lennox, K. A., Behlke, M. A., & Davidson, B. L. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.59 · Cited by 214
Zhu, G., Niu, G., & Chen, X. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00291 · Cited by 213
A synthetic molecular system capable of mirror-image genetic replication and transcription
Wang, Z., Xu, W., Liu, L., & Zhu, T. F. (2016) · Nature Chemistry · doi:10.1038/nchem.2517 · Cited by 209
Mirror-design of L-oligonucleotide ligands binding to L-arginine
Nolte, A., Klußmann, S., Bald, R., Erdmann, V. A., & Fürste, J. P. (1996) · Nature Biotechnology · doi:10.1038/nbt0996-1116 · Cited by 206
Unlocking the Sugar “Steric Gate” of DNA Polymerases
Brown, J. A., & Suo, Z. (2011) · Biochemistry · doi:10.1021/bi101915z · Cited by 205
A semisynthetic organism engineered for the stable expansion of the genetic alphabet
Zhang, Y., Lamb, B. M., Feldman, A. W., Zhou, A. X., Lavergne, T., Li, L., & Romesberg, F. E. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616443114 · Cited by 203
Latham, J. A., Johnson, R., & Toole, J. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.14.2817 · Cited by 200
Malyshev, D. A., & Romesberg, F. E. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201502890 · Cited by 200
Selection of DNA aptamers with two modified bases
Gawande, B. N., Rohloff, J. C., Carter, J. D., von Carlowitz, I., Zhang, C., Schneider, D. J., & Janjic, N. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615475114 · Cited by 194
Wilds, C. J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.18.3625 · Cited by 188
Improvements in siRNA properties mediated by 2'-deoxy-2'-fluoro- -D-arabinonucleic acid (FANA)
Dowler, T. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl033 · Cited by 188
Aptamer–nanoparticle complexes as powerful diagnostic and therapeutic tools
Jo, H., & Ban, C. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.44 · Cited by 188
A cross-chiral RNA polymerase ribozyme
Sczepanski, J. T., & Joyce, G. F. (2014) · Nature · doi:10.1038/nature13900 · Cited by 186
A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia
Mallikaratchy, P. R., Ruggiero, A., Gardner, J. R., Kuryavyi, V., Maguire, W. F., Heaney, M. L., McDevitt, M. R., Patel, D. J., & Scheinberg, D. A. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq996 · Cited by 186
Catalytic DNA (deoxyribozymes) for synthetic applications—current abilities and future prospects
Silverman, S. K. (2008) · Chemical Communications · doi:10.1039/b807292m · Cited by 183
Modified RNA sequence pools for in vitro selection
Lin, Y., Qiu, Q., Gill, S. C., & Jayasena, S. D. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.24.5229 · Cited by 182
The XNA world: progress towards replication and evolution of synthetic genetic polymers
Pinheiro, V. B., & Holliger, P. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.05.198 · Cited by 182
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C., Kellogg, E., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980002x · Cited by 181
Improved thrombin binding aptamer by incorporation of a single unlocked nucleic acid monomer
Pasternak, A., Hernandez, F. J., Rasmussen, L. M., Vester, B., & Wengel, J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq823 · Cited by 177
Effect of Chemical Modifications on Aptamer Stability in Serum
Kratschmer, C., & Levy, M. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0680 · Cited by 177
Nuclease Resistance and Antisense Activity of Modified Oligonucleotides Targeted to Ha-
Monia, B. P., Johnston, J. F., Sasmor, H., & Cummins, L. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14533 · Cited by 176
A general strategy for expanding polymerase function by droplet microfluidics
Larsen, A. C., Dunn, M. R., Hatch, A., Sau, S. P., Youngbull, C., & Chaput, J. C. (2016) · Nature Communications · doi:10.1038/ncomms11235 · Cited by 175
Highly specific unnatural base pair systems as a third base pair for PCR amplification
Yamashige, R., Kimoto, M., Takezawa, Y., Sato, A., Mitsui, T., Yokoyama, S., & Hirao, I. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1068 · Cited by 170
Toward Safe Genetically Modified Organisms through the Chemical Diversification of Nucleic Acids
Herdewijn, P., & Marlière, P. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900083 · Cited by 169
DNA Catalysis: The Chemical Repertoire of DNAzymes
Hollenstein, M. (2015) · Molecules · doi:10.3390/molecules201119730 · Cited by 169
Self-citationAnalysis of In Vitro Aptamer Selection Parameters
McKeague, M., McConnell, E. M., Cruz-Toledo, J., Bernard, E. D., Pach, A., Mastronardi, E., Zhang, X., Beking, M., Francis, T., Giamberardino, A., et al. (2015) · Journal of Molecular Evolution · doi:10.1007/s00239-015-9708-6 · Cited by 168
Improving the Stability of Aptamers by Chemical Modification
E. Wang, R., Wu, H., Niu, Y., & Cai, J. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797189565 · Cited by 168
Lincoff, A. M., Mehran, R., Povsic, T. J., Zelenkofske, S. L., Huang, Z., Armstrong, P. W., Steg, P. G., Bode, C., Cohen, M. G., Buller, C. E. H., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00515-2 · Cited by 167
Kaul, C., Müller, M., Wagner, M., Schneider, S., & Carell, T. (2011) · Nature Chemistry · doi:10.1038/nchem.1117 · Cited by 163
Structural Insights into the Processing of Nucleobase-Modified Nucleotides by DNA Polymerases
Hottin, A., & Marx, A. (2016) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00544 · Cited by 163
Webber, J. P., Stone, T., Katilius, E., Smith, B. C., Gordon, B., Mason, M. D., Tabi, Z., Brewis, I. A., & Clayton, A. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.032136 · Cited by 162
Shoji, A., Kuwahara, M., Ozaki, H., & Sawai, H. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067098n · Cited by 161
Schwoebel, F., van Eijk, L. T., Zboralski, D., Sell, S., Buchner, K., Maasch, C., Purschke, W. G., Humphrey, M., Zöllner, S., Eulberg, D., et al. (2013) · Blood · doi:10.1182/blood-2012-09-456756 · Cited by 158
Sakthivel, K., & Barbas III, C. F. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981102)37:20<2872::aid-anie2872>3.0.co;2-5 · Cited by 158
Kim, E., Jung, Y., Choi, H., Yang, J., Suh, J., Huh, Y., Kim, K., & Haam, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.030 · Cited by 157
Duerschmied, D., Merhi, Y., Tanguay, J., Hutabarat, R. M., GILBERT, J., Wagner, D. D., Schaub, R. G., Diener, J. L., & Lagassé, H. A. D. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03459.x · Cited by 156
Hocek, M. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo5020799 · Cited by 153
Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA
Fattal, E., & Bochot, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.020 · Cited by 152
Gupta, S., Hirota, M., Waugh, S. M., Murakami, I., Suzuki, T., Muraguchi, M., Shibamori, M., Ishikawa, Y., Jarvis, T. C., Carter, J. D., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532580 · Cited by 151
A Versatile Approach Towards Nucleobase‐Modified Aptamers
Tölle, F., Brändle, G. M., Matzner, D., & Mayer, G. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201503652 · Cited by 150
Perrin, D. M., Garestier, T., & Hélène, C. (2001) · Journal of the American Chemical Society · doi:10.1021/ja003290s · Cited by 146
Molecular Elucidation of Disease Biomarkers at the Interface of Chemistry and Biology
Zhang, L., Wan, S., Jiang, Y. Y., Wang, Y., Fu, T., Liu, Q., Cao, Z., Qiu, L., & Tan, W. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b10646 · Cited by 144
Evolution of thermophilic DNA polymerases for the recognition and amplification of C2ʹ-modified DNA
Chen, T., Hongdilokkul, N., Liu, Z., Adhikary, R., Tsuen, S. S., & Romesberg, F. E. (2016) · Nature Chemistry · doi:10.1038/nchem.2493 · Cited by 143
Hendrix, C., Rosemeyer, H., Verheggen, I., Aerschot, A. A. V., Seela, F., & Herdewijn, P. A. (1997) · Chemistry - A European Journal · doi:10.1002/chem.19970030118 · Cited by 140
Selecting Aptamers for a Glycoprotein through the Incorporation of the Boronic Acid Moiety
Li, M., Lin, N., Huang, Z., Du, L., Altier, C., Fang, H., & Wang, B. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801510d · Cited by 139
Matsunaga, K., Kimoto, M., & Hirao, I. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b10767 · Cited by 136
Synthesis of DNA/RNA and Their Analogs via Phosphoramidite and H-Phosphonate Chemistries
Roy, S., & Caruthers, M. H. (2013) · Molecules · doi:10.3390/molecules181114268 · Cited by 135
Hollenstein, M., Hipolito, C. J., Lam, C. H., & Perrin, D. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1070 · Cited by 131
Self-citationAptamer-targeted cell-specific RNA interference
Zhou, J., & Rossi, J. J. (2010) · Silence · doi:10.1186/1758-907x-1-4 · Cited by 128
Aptamer-Mediated Delivery of Splice-Switching Oligonucleotides to the Nuclei of Cancer Cells
Kotula, J. W., Pratico, E. D., Ming, X., Nakagawa, O., Juliano, R. L., & Sullenger, B. A. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0347 · Cited by 124
Ferreira‐Bravo, I. A., Cozens, C., Holliger, P., & DeStefano, J. J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1057 · Cited by 124
Biological applications of xeno nucleic acids
Morihiro, K., Kasahara, Y., & Obika, S. (2016) · Molecular BioSystems · doi:10.1039/c6mb00538a · Cited by 123
Evoking picomolar binding in RNA by a single phosphorodithioate linkage
Abeydeera, N., Egli, M., Cox, N., Mercier, K., Conde, J. N., Pallan, P. S., Mizurini, D. M., Sierant, M., Hibti, F.-E., Hassell, T., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw725 · Cited by 122
Kwon, Y. S., Raston, N. H. A., & Gu, M. B. (2013) · Chemical Communications · doi:10.1039/c3cc47108j · Cited by 121
Expanded Genetic Alphabets in the Polymerase Chain Reaction
Yang, Z., Chen, F., Chamberlin, S. G., & Benner, S. A. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200905173 · Cited by 121
Isolation of virus-neutralizing RNAs from a large pool of random sequences.
Pan, W., Craven, R. C., Qiu, Q., Wilson, C. B., Wills, J. W., Golovine, S., & Wang, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11509 · Cited by 120
Wu, G., Dai, Z., Tang, X., Lin, Z., Lo, P. K., Meyyappan, M., & Lai, K. W. C. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700736 · Cited by 119
Generation of Aptamers with an Expanded Chemical Repertoire
Diafa, S., & Hollenstein, M. (2015) · Molecules · doi:10.3390/molecules200916643 · Cited by 116
Self-citationBattersby, T. R., Ang, D. N., Burgstaller, P., Jurczyk, S. C., Bowser, M. T., Buchanan, D. D., Kennedy, R. T., & Benner, S. A. (1999) · Journal of the American Chemical Society · doi:10.1021/ja9816436 · Cited by 114
Evolution of sequence-defined highly functionalized nucleic acid polymers
Chen, Z., Lichtor, P. A., Berliner, A. P., Chen, J. C., & Liu, D. R. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0008-9 · Cited by 110
Crystal Structure of Interleukin-6 in Complex with a Modified Nucleic Acid Ligand
Gelinas, A. D., Davies, D. R., Edwards, T. E., Rohloff, J. C., Carter, J. D., Zhang, C., Gupta, S., Ishikawa, Y., Hirota, M., Nakaishi, Y., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532697 · Cited by 109
Recent strategies targeting HIV glycans in vaccine design
Horiya, S., MacPherson, I. S., & Krauss, I. J. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1685 · Cited by 107
Nellore, B. P. V., Kanchanapally, R., Pramanik, A., Sinha, S. S., Chavva, S. R., Hamme, A. T., & Ray, P. C. (2015) · Bioconjugate Chemistry · doi:10.1021/bc500503e · Cited by 107
Efficacy of Base-Modification on Target Binding of Small Molecule DNA Aptamers
Imaizumi, Y., Kasahara, Y., Fujita, H., Kitadume, S., Ozaki, H., Endoh, T., Kuwahara, M., & Sugimoto, N. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4012222 · Cited by 106
Lee, C. H., Lee, S.-H., Kim, J. H., Noh, Y.-H., Noh, G., & Lee, S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.30 · Cited by 106
Reinstein, O., Yoo, M., Han, C., Palmo, T., Beckham, S. A., Wilce, M. C. J., & Johnson, P. E. (2013) · Biochemistry · doi:10.1021/bi4010039 · Cited by 104
Oberthüer, D., Achenbach, J., Gabdulkhakov, A. G., Buchner, K., Maasch, C., Falke, S., Rehders, D., Klußmann, S., & Betzel, C. (2015) · Nature Communications · doi:10.1038/ncomms7923 · Cited by 104
Metal‐Mediated Base Pairs: From Characterization to Application
Jash, B., & Müller, J. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201703518 · Cited by 103
Anzahaee, M. Y., Watts, J. K., Alla, N. R., Nicholson, A. W., & Damha, M. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja109817p · Cited by 102
Nielsen, P., Dreio⊘e, L. H., & Wengel, J. (1995) · Bioorganic & Medicinal Chemistry · doi:10.1016/0968-0896(94)00143-q · Cited by 101
New NTP analogs: the synthesis of 4′-thioUTP and 4′-thioCTP and their utility for SELEX
Kato, Y., Minakawa, N., Komatsu, Y., Kamiya, H., Ogawa, N., Harashima, H., & Matsuda, A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki578 · Cited by 101
Alternative Watson–Crick Synthetic Genetic SystemsPreprint
Benner, S. A., Karalkar, N. B., Hoshika, S., Laos, R., Shaw, R. W., Matsuura, M. F., Fajardo, D. A., & Moussatche, P. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023770 · Cited by 101
Cohen, M. G., Purdy, D. A., Rossi, J. S., Grinfeld, L. R., Myles, S. K., Aberle, L. H., Greenbaum, A. B., Fry, E. T. A., Chan, M. Y., Tonkens, R. M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.927756 · Cited by 100
LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1
Darfeuille, F. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh636 · Cited by 97
Niu, W., Chen, X., Tan, W., & Veige, A. S. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201602702 · Cited by 97
Röthlisberger, P., Gasse, C., & Hollenstein, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112430 · Cited by 97
Self-citationMarušič, M., Veedu, R. N., Wengel, J., & Plavec, J. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt697 · Cited by 94
Evaluating TNA stability under simulated physiological conditions
Culbertson, M. C., Temburnikar, K. W., Sau, S. P., Liao, J.-Y., Bala, S., & Chaput, J. C. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.03.118 · Cited by 94
Universality of LNA-mediated high-affinity nucleic acid recognition
Singh, S. K., & Wengel, J. (1998) · Chemical Communications · doi:10.1039/a801571f · Cited by 93
Selection of 2′-Fluoro-Modified Aptamers with Optimized Properties
Thirunavukarasu, D., Chen, T., Liu, Z., Hongdilokkul, N., & Romesberg, F. E. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b13132 · Cited by 92
Current preclinical small interfering RNA (siRNA)-based conjugate systems for RNA therapeutics
Hyeon, L. S., Kang, Y. Y., Jang, H.-E., & Mok, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.009 · Cited by 89
Jilma‐Stohlawetz, P., Gilbert, J., Gorczyca, M. E., Knöbl, P., & Jilma, B. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-02-0069 · Cited by 89
Zhang, L., Yang, Z., Trinh, T. L., Teng, I., Wang, S., Bradley, K. M., Hoshika, S., Wu, Q., Cansız, S., Rowold, D. J., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201605058 · Cited by 89
A thermostable d-polymerase for mirror-image PCR
Pech, A., Achenbach, J., Jahnz, M., Schülzchen, S., Jarosch, F., Bordusa, F., & Klußmann, S. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx079 · Cited by 88
Vaish, N. K., Larralde, R., Fraley, A. W., Szostak, J. W., & McLaughlin, L. W. (2003) · Biochemistry · doi:10.1021/bi027354i · Cited by 85
DNA polymerases and biotechnological applications
Aschenbrenner, J., & Marx, A. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.04.005 · Cited by 85
Nucleic Acids with a Six‐Membered ‘Carbohydrate’ Mimic in the Backbone
Herdewijn, P. A. (2010) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900185 · Cited by 84
In Vitro Selection of Diversely Functionalized Aptamers
Kong, D., Yeung, W., & Hili, R. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b07241 · Cited by 83
Advances in the development of aptamer drug conjugates for targeted drug delivery
Chen, K., Liu, B., Yu, B., Zhong, W., Lü, Y., Zhang, J., Liao, J., Liu, J., Pu, Y. D., Qiu, L., et al. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1438 · Cited by 82
Biostable L-DNAzyme for Sensing of Metal Ions in Biological Systems
Cui, L., Peng, R., Fu, T., Zhang, X., Wu, C., Chen, H., Liang, H., Yang, C. J., & Tan, W. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04170 · Cited by 81
Recognition of threosyl nucleotides by DNA and RNA polymerases
Kempeneers, V. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg833 · Cited by 81
DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics
Latorre, A., Posch, C., Garcimartín, Y., Celli, A., Sanlorenzo, M., Vujic, I., Ma, J. A., Zekhtser, M., Rappersberger, K., Ortiz‐Urda, S., et al. (2014) · Nanoscale · doi:10.1039/c4nr00019f · Cited by 81
Post-SELEX Chemical Optimization of a Trypanosome-Specific RNA Aptamer
Göringer, H. U., Adler, A., Forster, N., & Homann, M. (2008) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620708783398331 · Cited by 80
Watson, S. R., Chang, Y.-F., O'Connell, D., WEIGAND, L., Ringquist, S., & Parma, D. H. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.63 · Cited by 79
PEGylation and Biodistribution of an anti-MUC1 Aptamer in MCF-7 Tumor-Bearing Mice
Pieve, C. D., Blackshaw, E., Missailidis, S., & Perkins, A. C. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300128r · Cited by 79
Pi, F., Zhang, H., Li, H., Thiviyanathan, V., Gorenstein, D. G., Sood, A. K., & Guo, P. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.11.015 · Cited by 78
Combinatorial Screening of DNA Aptamers for Molecular Imaging of HER2 in Cancer
Zhu, G., Zhang, H., Jacobson, O., Wang, Z., Chen, H., Yang, X., Niu, G., & Chen, X. S. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00746 · Cited by 78
Advances in cancer stem cell targeting: How to strike the evil at its root
Pützer, B. M., Solanki, M., & Herchenröder, O. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.013 · Cited by 77
An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells
Ara, M. N., Matsuda, T., Hyodo, M., Sakurai, Y., Hatakeyama, H., Ohga, N., Hida, K., & Harashima, H. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.087 · Cited by 76
Architecture of high-affinity unnatural-base DNA aptamers toward pharmaceutical applications
Matsunaga, K., Kimoto, M., Hanson, C. A., Sanford, M. E., Young, H. A., & Hirao, I. (2015) · Scientific Reports · doi:10.1038/srep18478 · Cited by 76
Boron-containing aptamers to ATP
Lato, S. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.6.1401 · Cited by 75
Ren, X., Gelinas, A. D., von Carlowitz, I., Janjić, N., & Pyle, A. M. (2017) · Nature Communications · doi:10.1038/s41467-017-00864-2 · Cited by 72
Binding of a Structured D-RNA Molecule by an L-RNA Aptamer
Sczepanski, J. T., & Joyce, G. F. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406634g · Cited by 71
Bright Fluorescent Nanotags from Bottlebrush Polymers with DNA-Tipped Bristles
Fouz, M. F., Mukumoto, K., Averick, S. E., Molinar‐Inglis, O., McCartney, B. M., Matyjaszewski, K. A., Armitage, B. A., & Das, S. R. (2015) · ACS Central Science · doi:10.1021/acscentsci.5b00259 · Cited by 69
Baccaro, A., Steck, A., & Marx, A. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201105717 · Cited by 69
DNA Ligase-Mediated Translation of DNA Into Densely Functionalized Nucleic Acid Polymers
Hili, R., Niu, J., & Liu, D. R. (2012) · Journal of the American Chemical Society · doi:10.1021/ja311331m · Cited by 68
2´-Deoxy Purine, 2´-O-Methyl Pyrimidine (dRmY) Aptamers as Candidate Therapeutics
Burmeister, P. E., Wang, C., Killough, J. R., Lewis, S. D., Horwitz, L. R., Ferguson, A., Thompson, K. M., Pendergrast, P. S., McCauley, T. G., Kurz, M., et al. (2006) · Oligonucleotides · doi:10.1089/oli.2006.16.337 · Cited by 67
Chiral Stationary Phase Based on a Biostable l -RNA Aptamer
Brumbt, A., Ravelet, C., Grosset, C., Ravel, A., Villet, A., & Peyrin, É. (2005) · Analytical Chemistry · doi:10.1021/ac048344l · Cited by 66
Kasahara, Y., Irisawa, Y., Fujita, H., Yahara, A., Ozaki, H., Obika, S., & Kuwahara, M. (2013) · Analytical Chemistry · doi:10.1021/ac400058z · Cited by 65
The expanding world of DNA and RNA
Chen, T., Hongdilokkul, N., Liu, Z., Thirunavukarasu, D., & Romesberg, F. E. (2016) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2016.08.001 · Cited by 65
A Hybrid DNA Aptamer–Dendrimer Nanomaterial for Targeted Cell Labeling
Zhou, J., Soontornworajit, B., Martin, J. T., Sullenger, B. A., Gilboa, E., & Wang, Y. (2009) · Macromolecular Bioscience · doi:10.1002/mabi.200900046 · Cited by 63
An Aptamer Intrinsically Comprising 5‐Fluoro‐2′‐deoxyuridine for Targeted Chemotherapy
Kruspe, S., & Hahn, U. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201405778 · Cited by 62
Thermodynamics of RNA duplexes modified with unlocked nucleic acid nucleotides
Pasternak, A., & Wengel, J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq561 · Cited by 61
Aptamers as Drug Delivery Vehicles
Kruspe, S., Mittelberger, F., Szameit, K., & Hahn, U. (2014) · ChemMedChem · doi:10.1002/cmdc.201402163 · Cited by 60
Directed Evolution of Polymerases To Accept Nucleotides with Nonstandard Hydrogen Bond Patterns
Laos, R., Shaw, R. W., Leal, N. A., Gaucher, E. A., & Benner, S. A. (2013) · Biochemistry · doi:10.1021/bi400558c · Cited by 60
Customised nucleic acid libraries for enhanced aptamer selection and performance
Pfeiffer, F., Rosenthal, M., Siegl, J., Ewers, J., & Mayer, G. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.03.026 · Cited by 59
Cited by
Metal–Organic Framework Nanocarriers for Drug Delivery in Biomedical Applications
Sun, Y., Zheng, L., Yang, Y., Qian, X., Fu, T., Li, X., Yang, Z., Yan, H., Cui, C., & Tan, W. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00423-3 · Cited by 723
Wearable chemical sensors for biomarker discovery in the omics era
Sempionatto, J. R., Lasalde-Ramírez, J. A., Mahato, K., Wang, J., & Gao, W. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00439-w · Cited by 613
Mehta, M., Deeksha, Tewari, D., Gupta, G., Awasthi, R., Singh, H., Pandey, P., Chellappan, D. K., Wadhwa, R., Collet, T., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.05.028 · Cited by 397
SELEX: Critical factors and optimization strategies for successful aptamer selection
Kohlberger, M., & Gadermaier, G. (2022) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2244 · Cited by 341
Recent progress in non-native nucleic acid modifications
McKenzie, L. K., El-Khoury, R., Thorpe, J. D., Damha, M. J., & Hollenstein, M. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01430c · Cited by 300
Self-citation
Metadata
- Authors
- Röthlisberger, P., & Hollenstein, M.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 134
- Pages
- 3-21
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4211092517
- Cited by
- 413
- References
- 263
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.